Eli Lilly Doubles Irish Cell Therapy Plant Spend to $1 Billion

GALWAY, IRELAND--April 12, 2023--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Pharma major Eli Lilly (NYSE:LLY) (Indianapolis, Indiana) is to more than double its investment to US$1 billion in a new biologics drug substance manufacturing facility in Limerick, Ireland.

Within this article: Details doubling of investment in new plant, scope, timeline, additional solar project